Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
New hope for advanced stomach cancer? phase 3 trial tests zanidatamab combo
Disease control OngoingThis study tests whether a new drug called zanidatamab, given with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancer. About 920 adults whose cancer has spread or cannot…
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Epidiolex liver check: study tracks long-term injury risk
Knowledge-focused OngoingThis study checks if long-term use of Epidiolex (cannabidiol) can cause liver damage or scarring in people with certain seizure disorders. It includes 154 participants who already take or will start Epidiolex for Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis com…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC